Simpson, Eric L.
Silverberg, Jonathan I.
Thyssen, Jacob P.
Viguier, Manuelle
Thaçi, Diamant
de Bruin-Weller, Marjolein
Weidinger, Stephan
Chan, Gary
DiBonaventura, Marco
Biswas, Pinaki
Feeney, Claire
Koulias, Christopher
Cork, Michael J.
Funding for this research was provided by:
Pfizer Inc
Article History
Accepted: 11 April 2023
First Online: 22 May 2023
Declarations
:
: This study and the Open Access fee were sponsored by Pfizer Inc.
: ELS received grants from Pfizer Inc., Eli Lilly and Company, Kyowa Kirin, LEO Pharma, Merck, and Regeneron and personal fees from Pfizer Inc., Bausch Health (Valeant), Dermira, Eli Lilly and Company, Galderma, LEO Pharma, Menlo Therapeutics, Novartis, Regeneron, and Sanofi Genzyme. JIS served as an investigator for Celgene, Eli Lilly and Company, F. Hoffmann-La Roche, Menlo Therapeutics, Realm Therapeutics, Regeneron, and Sanofi; as a consultant for Pfizer Inc., AbbVie, Anacor, AnaptysBio, Arena Pharmaceuticals, Dermavant, Dermira, Eli Lilly and Company, Galderma, GlaxoSmithKline, Glenmark, Incyte, Kiniksa Pharmaceuticals, LEO Pharma, Menlo Therapeutics, Novartis, Realm Therapeutics, Regeneron, and Sanofi Genzyme; and as a speaker for Regeneron and Sanofi-Genzyme. JPT is an advisor for Pfizer Inc., AbbVie, Almirall, Arena Pharmaceuticals, Aslan Pharmaceuticals, Coloplast, Eli Lilly and Company, LEO Pharma, OM Pharma, Regeneron, Sanofi-Genzyme, and Union Therapeutics; a speaker for Pfizer Inc., AbbVie, Almirall, Eli Lilly and Company, LEO Pharma, Regeneron, and Sanofi-Genzyme; and has received research grants from Pfizer Inc., Regeneron, and Sanofi-Genzyme. MV is an investigator, board member, and consultant for AbbVie, Almirall, Boehringer Ingelheim, Eli Lilly and Company, Janssen, Medac, Novartis, and Sanofi. DT is a consultant, advisory board member, and investigator for Pfizer Inc., AbbVie, Almirall, Amgen, Beiersdorf, Bristol Myers Squibb, Boehringer Ingelheim, Eli Lilly and Company, Janssen-Cilag, LEO Pharma, Novartis, Regeneron, Samsung, Sandoz, Sanofi, Sun Pharma, and UCB Pharma. MdBW is a consultant, advisory board member, and/or speaker for Pfizer, AbbVie, Almirall, Arena, Aslan, Eli Lilly and Company, Galderma, Janssen, LEO Pharma, Regeneron, and Sanofi Genzyme. SW has received institutional research grants from La Roche-Posay, LEO Pharma, and Sanofi Deutschland GmbH; has performed consultancies for Pfizer Inc., AbbVie, Eli Lilly and Company, Kymab, LEO Pharma, Novartis, Regeneron, and Sanofi Genzyme; has lectured at educational events sponsored by AbbVie, Galderma, LEO Pharma, Novartis, Regeneron, and Sanofi Genzyme; and is involved in performing clinical trials with many pharmaceutical industries that manufacture drugs used for the treatment of psoriasis and atopic dermatitis. GC, MD, and PB are employees and shareholders of Pfizer Inc. CF is an employee and shareholder of Pfizer Ltd. CK is an employee of Pfizer Hellas S.A. MJC has been a clinical trial investigator for Pfizer Inc., Atopix, Galapagos, Hyphens, Johnson & Johnson, Kymab, LEO Pharma, L’Oreal/La Roche-Posay, Novartis, Regeneron, and Sanofi Genzyme and an advisory board member, consultant, and/or invited lecturer for Pfizer Inc., AbbVie, Amlar, Astellas, Atopix, Boots, Dermavant, Galapagos, Galderma, Hyphens, Johnson & Johnson, Kymab, LEO Pharma, L’Oreal/La Roche-Posay, Menlo Therapeutics, Novartis, Oxagen, Procter & Gamble, Reckitt Benckiser, Regeneron, and Sanofi-Genzyme.
: All study documents and procedures were approved by the appropriate institutional review boards/ethics committees at each study site. The studies were conducted in compliance with the ethical principles originating in or derived from the Declaration of Helsinki and in compliance with all International Council for Harmonization Good Clinical Practice Guidelines. All local regulatory requirements were followed. This research was approved by institutional review boards or ethics committees at each study site. An internal review committee monitored the safety of patients throughout the studies.
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: Upon request, and subject to review, Pfizer will provide the data that support the findings of this study. Subject to certain criteria, conditions, and exceptions, Pfizer may also provide access to the related individual de-identified participant data. See ExternalRef removed for more information.
: GC, PB, and CK contributed to the study concept and design. PB conducted the statistical analysis of the data. ELS, JIS, JPT, MV, DT MBW, SW, GC, MD, PB, CF, CK, and MJC interpreted the data, provided critical feedback on the manuscript, approved the final manuscript for submission, and are accountable for the accuracy and integrity of the manuscript.